Company Filing History:
Years Active: 2016
Title: Christopher Donovan Craig: Innovator in Pharmaceutical Composition
Introduction
Christopher Donovan Craig is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dispersions for drug delivery.
Latest Patents
Christopher holds a patent for a solid dispersion of an ERB2 (HER2) inhibitor. This patent, titled "Solid dispersions of a ERB2 (HER2) inhibitor," describes a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine. The patent also outlines processes for preparing the solid dispersion and a pharmaceutical composition comprising this solid dispersion, along with its uses.
Career Highlights
Christopher is currently associated with Array Biopharma Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing drug formulations to improve efficacy and patient outcomes.
Collaborations
He collaborates with esteemed colleagues, including David Fry and Christopher M Lindemann, contributing to a dynamic research environment that fosters innovation.
Conclusion
Christopher Donovan Craig is a dedicated inventor whose work in pharmaceutical compositions is paving the way for advancements in drug delivery systems. His contributions are vital to the ongoing evolution of medical treatments.